TCTR20210507005
Completed
Phase 1
The efficacy and safety of picosecond 1064 nm Nd:YAG laser in treatment of post sclerotherapy hyperpigmentation: a pilot study.
Overview
- Phase
- Phase 1
- Status
- Completed
- Enrollment
- 12
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Years to 80 Years (—)
- Sex
- All
Inclusion Criteria
- •1\. Patient is diagnosed as post\-sclerotherapy hyperpigmentation from sclerotherapy using 0\.1\- 1% polidocanol in liquid or foam solution. Off\- treatment time is 3\-months period.
- •2\. No truncal reflux by Duplex ultrasound study.
- •3\. The patient has 2 lesions or more.
- •4\. Those lesions has similar melanin index.
- •5\. Age \> 18 years.
- •6\. Fitzpatrick skin type III\-V
- •7\. Patient could make a visit as appointed
- •8\. Patient has no history of using bleaching agents such as hydroquinone, retinoids prior to the study.
Exclusion Criteria
- •1\. Patient is receiving anticoagulant, minocycline or iron supplements.
- •2\. Patient has received laser treatment on the study sites within 6 months.
- •3\. Pregnant patient
- •4\. Patient with history of photosensitive conditions
- •5\. Patient with history or risk of keloidal scar formation
Investigators
Similar Trials
Not yet recruiting
Not Applicable
The efficacy of a super-long pulse 1064 Nd:YAG for localized noninvasive subcutaneous fat reduction of flanks; a prospective clinical trialSubject who has clinically evident of excess fat tissue on flanks (love handles) area,defined by easily seen the fatty bulges extend on the sides of subjects’ waistline or easily pinch the fatty buhyperthermic laser lipolysis,PIANO mode,super long pulse񫫨 Nd:YAG laserTCTR20201101001/A17
Unknown
Not Applicable
The Efficacy of 1,064-nm Picosecond Laser With Microlens Array for the Treatment of Abdominal Striae DistensaeStriae AlbaNCT04456257Mahidol University12
Completed
Phase 4
Clinical outcome of 1064-nm fractional picosecond laser for the treatment of post-mastectomy scar in transmen: A randomized controlled trial studyEfficacy and safety of 1064-nm fractional picosecond laser (FxPico) treatment for hypertrophic and atrophic post-mastectomy scars in transmen.Atrophic scar, Female-to-male transgender, Hypertrophic scar, Picosecond laser, Post-mastectomy scar, Transgender men, and Transmen.TCTR20230306002Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi hospital22
Unknown
Not Applicable
The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot StudyEnlarged PoresNCT04471948Mahidol University26
Unknown
Phase 4
Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions TreatmentBenign Pigmented LesionsNCT02800525Mahidol University20